Vertex Pharmaceuticals Total Assets 2012-2025 | VRTX

Vertex Pharmaceuticals total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.

Vertex Pharmaceuticals total assets for the quarter ending September 30, 2025 were $24.862B, a 11.79% increase year-over-year.
Vertex Pharmaceuticals total assets for 2024 were $22.533B, a 0.87% decline from 2023.
Vertex Pharmaceuticals total assets for 2023 were $22.73B, a 25.23% increase from 2022.
Vertex Pharmaceuticals total assets for 2022 were $18.151B, a 35.13% increase from 2021.

Vertex Pharmaceuticals Annual Total Assets (Millions of US $)
2024	$22,533
2023	$22,730
2022	$18,151
2021	$13,433
2020	$11,752
2019	$8,318
2018	$6,246
2017	$3,546
2016	$2,897
2015	$2,499
2014	$2,335
2013	$2,319
2012	$2,759
2011	$2,204

Vertex Pharmaceuticals Quarterly Total Assets (Millions of US $)
2025-09-30	$24,862
2025-06-30	$24,037
2025-03-31	$22,881
2024-12-31	$22,533
2024-09-30	$22,240
2024-06-30	$20,132
2024-03-31	$23,917
2023-12-31	$22,730
2023-09-30	$21,726
2023-06-30	$20,349
2023-03-31	$18,974
2022-12-31	$18,151
2022-09-30	$16,706
2022-06-30	$15,582
2022-03-31	$14,256
2021-12-31	$13,433
2021-09-30	$12,619
2021-06-30	$12,222
2021-03-31	$12,115
2020-12-31	$11,752
2020-09-30	$11,302
2020-06-30	$10,216
2020-03-31	$8,893
2019-12-31	$8,318
2019-09-30	$7,515
2019-06-30	$7,033
2019-03-31	$6,543
2018-12-31	$6,246
2018-09-30	$4,621
2018-06-30	$4,335
2018-03-31	$3,953
2017-12-31	$3,546
2017-09-30	$3,198
2017-06-30	$3,286
2017-03-31	$2,947
2016-12-31	$2,897
2016-09-30	$2,610
2016-06-30	$2,549
2016-03-31	$2,488
2015-12-31	$2,499
2015-09-30	$2,434
2015-06-30	$2,374
2015-03-31	$2,166
2014-12-31	$2,335
2014-09-30	$2,406
2014-06-30	$2,118
2014-03-31	$2,197
2013-12-31	$2,319
2013-09-30	$2,583
2013-06-30	$2,584
2013-03-31	$2,392
2012-12-31	$2,759
2012-09-30	$2,719
2012-06-30	$2,605
2012-03-31	$2,346
2011-12-31	$2,204
2011-09-30	$2,092
2011-06-30	$1,763
2011-03-31	$1,538

Sector	Industry	Market Cap	Revenue
Medical	Medical - Biomedical and Genetics	$111.981B	$11.020B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.

Stock Name	Country	Market Cap	PE Ratio
AstraZeneca (AZN)	United Kingdom	$292.780B	20.65
Amgen (AMGN)	United States	$177.920B	15.11
Gilead Sciences (GILD)	United States	$154.973B	15.25
Bristol Myers Squibb (BMY)	United States	$112.496B	8.42
GSK (GSK)	United Kingdom	$98.292B	10.88
Regeneron Pharmaceuticals (REGN)	United States	$77.042B	19.98
CSL (CSLLY)	Australia	$57.238B	0.00
Argenex SE (ARGX)	Netherlands	$49.256B	61.16
Alnylam Pharmaceuticals (ALNY)	United States	$47.465B	1562.04
Insmed (INSM)	United States	$34.427B	0.00
BioNTech SE (BNTX)	Germany	$24.545B	0.00
Biogen (BIIB)	United States	$24.121B	9.82
Revolution Medicines (RVMD)	United States	$23.253B	0.00
Royalty Pharma (RPRX)	United States	$22.830B	8.75
Illumina (ILMN)	United States	$21.644B	32.49
Incyte (INCY)	United States	$20.851B	19.96
Genmab (GMAB)	Denmark	$20.717B	15.58
Exact Sciences (EXAS)	United States	$19.545B	539.11
Moderna (MRNA)	United States	$16.344B	0.00
Roivant Sciences (ROIV)	United Kingdom	$16.087B	0.00
Guardant Health (GH)	United States	$14.134B	0.00
Regencell Bioscience Holdings (RGC)	Hong Kong, SAR China	$13.564B	0.00
Swedish Orphan Biovitrum (BIOVF)	Sweden	$13.172B	24.50
Ascendis Pharma (ASND)	Denmark	$12.757B	0.00
Exelixis (EXEL)	United States	$11.786B	18.87
Avidity Biosciences (RNA)	United States	$10.926B	0.00
Bio-Techne Corp (TECH)	United States	$10.700B	39.92
BioMarin Pharmaceutical (BMRN)	United States	$10.488B	19.02
Jazz Pharmaceuticals (JAZZ)	Ireland	$10.294B	40.14
QIAGEN (QGEN)	Netherlands	$10.046B	19.07
Abivax SA (ABVX)	France	$9.126B	0.00
Repligen (RGEN)	United States	$9.120B	97.60
Axsome Therapeutics (AXSM)	United States	$8.937B	0.00
Arrowhead Pharmaceuticals (ARWR)	United States	$8.675B	0.00
Bio-Rad Laboratories (BIO.B)	United States	$8.381B	30.14
Halozyme Therapeutics (HALO)	United States	$8.374B	13.39
Krystal Biotech (KRYS)	United States	$8.266B	42.73
Praxis Precision Medicines (PRAX)	United States	$7.993B	0.00
Cytokinetics (CYTK)	United States	$7.651B	0.00
Nuvalent (NUVL)	United States	$7.580B	0.00
Cidara Therapeutics (CDTX)	United States	$6.960B	0.00
Merus (MRUS)	Netherlands	$6.826B	0.00
Rhythm Pharmaceuticals (RYTM)	United States	$6.782B	0.00
Vaxcyte (PCVX)	United States	$6.099B	0.00
PTC Therapeutics (PTCT)	United States	$5.819B	7.90
Belite Bio (BLTE)	United States	$5.819B	0.00
Cogent Biosciences (COGT)	United States	$5.544B	0.00
Apogee Therapeutics (APGE)	United States	$5.518B	0.00
ImmunityBio (IBRX)	United States	$5.437B	0.00
Structure Therapeutics (GPCR)	United States	$5.379B	0.00
Alkermes (ALKS)	Ireland	$5.223B	15.35
Protagonist Therapeutics (PTGX)	United States	$5.126B	132.24
CRISPR Therapeutics AG (CRSP)	Switzerland	$5.100B	0.00
Kymera Therapeutics (KYMR)	United States	$5.003B	0.00
Celcuity (CELC)	United States	$4.949B	0.00
TG Therapeutics (TGTX)	United States	$4.853B	11.00
Anbio Biotechnology (NNNN)	Germany	$4.681B	0.00
Mirum Pharmaceuticals (MIRM)	United States	$4.679B	0.00
Zealand Pharma (ZLDPF)	Denmark	$4.637B	4.70
Immunovant (IMVT)	United States	$4.605B	0.00
Scholar Rock Holding (SRRK)	United States	$4.587B	0.00
Akero Therapeutics (AKRO)	United States	$4.499B	0.00
Amicus Therapeutics (FOLD)	United States	$4.421B	358.25
CG Oncology (CGON)	United States	$4.415B	0.00
ACADIA Pharmaceuticals (ACAD)	United States	$4.397B	37.13
ADMA Biologics Inc (ADMA)	United States	$4.120B	29.34
Legend Biotech (LEGN)	United States	$4.089B	0.00
Arcellx (ACLX)	United States	$3.986B	0.00
Viking Therapeutics (VKTX)	United States	$3.834B	0.00
Ligand Pharmaceuticals (LGND)	United States	$3.798B	93.22
GRAIL (GRAL)	United States	$3.770B	0.00
Liquidia (LQDA)	United States	$3.300B	0.00
Terns Pharmaceuticals (TERN)	United States	$3.297B	0.00
Viridian Therapeutics (VRDN)	United States	$3.174B	0.00
Beam Therapeutics (BEAM)	United States	$3.168B	0.00
Arcutis Biotherapeutics (ARQT)	United States	$3.166B	0.00
IDEAYA Biosciences (IDYA)	United States	$3.142B	0.00
Xenon Pharmaceuticals (XENE)	Canada	$3.089B	0.00
Tarsus Pharmaceuticals (TARS)	United States	$3.020B	0.00
Kiniksa Pharmaceuticals (KNSA)	United Kingdom	$2.987B	87.58
Vera Therapeutics (VERA)	United States	$2.973B	0.00
Edgewise Therapeutics (EWTX)	United States	$2.900B	0.00
HUTCHMED (China) (HCM)	Hong Kong, SAR China	$2.800B	0.00
Erasca (ERAS)	United States	$2.729B	0.00
Disc Medicine (IRON)	United States	$2.678B	0.00
Adaptive Biotechnologies (ADPT)	United States	$2.675B	0.00
Denali Therapeutics (DNLI)	United States	$2.638B	0.00
Telix Pharmaceuticals (TLX)	Australia	$2.629B	0.00
Mineralys Therapeutics (MLYS)	United States	$2.591B	0.00
Spyre Therapeutics (SYRE)	United States	$2.579B	0.00
Twist Bioscience (TWST)	United States	$2.537B	0.00
Ascentage Pharma Group - (AAPG)	China	$2.525B	0.00
Apellis Pharmaceuticals (APLS)	United States	$2.523B	64.32
Travere Therapeutics (TVTX)	United States	$2.494B	0.00
Alumis (ALMS)	United States	$2.491B	0.00
Bavarian Nordic (BVNRY)	Denmark	$2.460B	6.68
Recursion Pharmaceuticals (RXRX)	United States	$2.428B	0.00
Arcus Biosciences (RCUS)	United States	$2.354B	0.00
WAVE Life Sciences (WVE)	Singapore	$2.282B	0.00
Mesoblast (MESO)	Australia	$2.239B	0.00
Sarepta Therapeutics (SRPT)	United States	$2.214B	0.00
Ultragenyx Pharmaceutical (RARE)	United States	$2.170B	0.00
Harmony Biosciences Holdings (HRMY)	United States	$2.086B	11.39
Zai Lab (ZLAB)	China	$2.080B	0.00
Immunome (IMNM)	United States	$2.055B	0.00
Nuvation Bio (NUVB)	United States	$2.006B	0.00
Maze Therapeutics (MAZE)	United States	$1.962B	0.00
ANI Pharmaceuticals (ANIP)	United States	$1.906B	14.78
Vericel (VCEL)	United States	$1.891B	155.83
Dianthus Therapeutics (DNTH)	United States	$1.891B	0.00
Olema Pharmaceuticals (OLMA)	United States	$1.863B	0.00
Dynavax Technologies (DVAX)	United States	$1.835B	53.90
MBX Biosciences (MBX)	United States	$1.820B	0.00
Syndax Pharmaceuticals (SNDX)	United States	$1.784B	0.00
Zymeworks (ZYME)	United States	$1.756B	0.00
Tango Therapeutics (TNGX)	United States	$1.752B	0.00
Sionna Therapeutics (SION)	United States	$1.745B	0.00
Celldex Therapeutics (CLDX)	United States	$1.704B	0.00
Immunocore Holdings (IMCR)	United Kingdom	$1.685B	0.00
Upstream Bio (UPB)	United States	$1.675B	0.00
NeoGenomics (NEO)	United States	$1.655B	0.00
Stoke Therapeutics (STOK)	United States	$1.639B	42.84
MannKind (MNKD)	United States	$1.600B	52.10
Agios Pharmaceuticals (AGIO)	United States	$1.586B	0.00
Precigen (PGEN)	United States	$1.560B	0.00
Monte Rosa Therapeutics (GLUE)	United States	$1.544B	74.09
Tyra Biosciences (TYRA)	United States	$1.536B	0.00
NovoCure (NVCR)	Jersey	$1.527B	0.00
Fortrea Holdings (FTRE)	United States	$1.525B	32.35
Certara (CERT)	United States	$1.515B	27.97
Alvotech (ALVO)	Luxembourg	$1.483B	21.39
Mind Medicine (MindMed) (MNMD)	United States	$1.480B	0.00
Nurix Therapeutics (NRIX)	United States	$1.477B	0.00
Intellia Therapeutics (NTLA)	United States	$1.448B	0.00
Kodiak Sciences (KOD)	United States	$1.440B	0.00
UniQure (QURE)	Netherlands	$1.423B	0.00
Biohaven (BHVN)	United States	$1.391B	0.00
Trevi Therapeutics (TRVI)	United States	$1.344B	0.00
AtaiBeckley Inc (ATAI)	Netherlands	$1.322B	0.00
Oculis Holding AG (OCS)	Switzerland	$1.321B	0.00
Oxford BioMedica (OXBDF)	United Kingdom	$1.309B	0.00
Novavax (NVAX)	United States	$1.302B	3.31
Rapport Therapeutics (RAPP)	United States	$1.278B	0.00
AnaptysBio (ANAB)	United States	$1.265B	0.00
Pharming Group (PHAR)	Netherlands	$1.263B	0.00
EyePoint (EYPT)	United States	$1.248B	0.00
AbCellera Biologics (ABCL)	Canada	$1.233B	0.00
Sana Biotechnology (SANA)	United States	$1.220B	0.00
Immatics (IMTX)	Germany	$1.195B	0.00
Palvella Therapeutics (PVLA)	United States	$1.180B	0.00
Oric Pharmaceuticals (ORIC)	United States	$1.180B	0.00
Castle Biosciences (CSTL)	United States	$1.168B	160.04
Septerna (SEPN)	United States	$1.167B	0.00
Zenas BioPharma (ZBIO)	United States	$1.082B	0.00
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.077B	0.00
Inhibrx Biosciences (INBX)	United States	$1.051B	0.00
Day One Biopharmaceuticals (DAWN)	United States	$1.043B	0.00
Nanobiotix S.A - (NBTX)	France	$1.016B	0.00
Compass Therapeutics (CMPX)	United States	$1.014B	0.00
Phathom Pharmaceuticals (PHAT)	United States	$1.004B	0.00
Ventyx Biosciences (VTYX)	United States	$0.991B	0.00
Rapt Therapeutics (RAPT)	United States	$0.973B	0.00
Inventiva S.A (IVA)	France	$0.950B	0.00
Iovance Biotherapeutics (IOVA)	United States	$0.937B	0.00
CureVac (CVAC)	Germany	$0.927B	0.00
Bicara Therapeutics (BCAX)	United States	$0.918B	0.00
CytomX Therapeutics (CTMX)	United States	$0.913B	13.47
BridgeBio Oncology Therapeutics (BBOT)	United States	$0.913B	0.00
Basilea Pharmaceutica AG (BPMUF)	Switzerland	$0.908B	0.00
GH Research (GHRS)	Ireland	$0.884B	0.00
Urogen Pharma (URGN)	United States	$0.880B	0.00
ArriVent BioPharma (AVBP)	United States	$0.861B	0.00
Bright Minds Biosciences (DRUG)	United States	$0.856B	0.00
Vir Biotechnology (VIR)	United States	$0.843B	0.00
Geron (GERN)	United States	$0.836B	0.00
DBV Technologies S.A (DBVT)	France	$0.834B	0.00
Janux Therapeutics (JANX)	United States	$0.828B	0.00
Pacira BioSciences (PCRX)	United States	$0.824B	9.44
MiMedx (MDXG)	United States	$0.803B	14.26
YD Bio (YDES)		$0.798B	0.00
Arvinas (ARVN)	United States	$0.784B	0.00
Arbutus Biopharma (ABUS)	United States	$0.781B	0.00
MapLight Therapeutics (MPLT)	United States	$0.771B	0.00
Gyre Therapeutics (GYRE)	United States	$0.740B	96.00
Kura Oncology (KURA)	United States	$0.736B	0.00
Annexon (ANNX)	United States	$0.726B	0.00
Jade Biosciences (JBIO)	United States	$0.725B	0.00
BioAge Labs (BIOA)	United States	$0.723B	0.00
Prime Medicine (PRME)	United States	$0.718B	0.00
Astria Therapeutics (ATXS)	United States	$0.712B	0.00
Cytek Biosciences (CTKB)	United States	$0.690B	0.00
REGENXBIO (RGNX)	United States	$0.689B	0.00
Sinovac Biotech (SVA)	China	$0.645B	0.00
Cullinan Therapeutics (CGEM)	United States	$0.633B	0.00
EnGene Holdings (ENGN)	Canada	$0.624B	0.00
Corvus Pharmaceuticals (CRVS)	United States	$0.601B	0.00
MeiraGTx Holdings (MGTX)	United States	$0.597B	0.00
Gossamer Bio (GOSS)	United States	$0.583B	0.00
Ginkgo Bioworks Holdings (DNA)	United States	$0.579B	0.00
Emergent Biosolutions (EBS)	United States	$0.577B	5.55
Keros Therapeutics (KROS)	United States	$0.575B	12.25
LENZ Therapeutics (LENZ)	United States	$0.572B	0.00
Invivyd (IVVD)	United States	$0.571B	0.00
SELLAS Life Sciences (SLS)	United States	$0.567B	0.00
Replimune (REPL)	United States	$0.552B	0.00
Myriad Genetics (MYGN)	United States	$0.552B	0.00
Fulcrum Therapeutics (FULC)	United States	$0.549B	0.00
CorMedix Inc (CRMD)	United States	$0.534B	4.95
Alto Neuroscience (ANRO)	United States	$0.533B	0.00
Evommune (EVMN)	United States	$0.530B	0.00
Design Therapeutics (DSGN)	United States	$0.529B	0.00
Ocugen (OCGN)	United States	$0.528B	0.00
LB Pharmaceuticals Inc (LBRX)	United States	$0.505B	0.00
Prothena (PRTA)	Ireland	$0.503B	0.00
Lexicon Pharmaceuticals (LXRX)	United States	$0.498B	0.00
Niagen Bioscience (NAGE)	United States	$0.494B	38.69
Northwest Biotherapeutics (NWBO)	United States	$0.473B	0.00
Kamada (KMDA)	Israel	$0.470B	22.69
Monopar Therapeutics (MNPR)	United States	$0.468B	0.00
PureTech Health (PRTC)	United States	$0.464B	0.00
Absci (ABSI)	United States	$0.454B	0.00
Bicycle Therapeutics (BCYC)	United Kingdom	$0.452B	0.00
ADC Therapeutics SA (ADCT)	Switzerland	$0.448B	0.00
Anavex Life Sciences (AVXL)	United States	$0.448B	0.00
Verastem (VSTM)	United States	$0.446B	0.00
Vanda Pharmaceuticals (VNDA)	United States	$0.441B	0.00
Prima BioMed (IMMP)	Australia	$0.433B	0.00
NovaBridge Biosciences (NBP)	United States	$0.430B	0.00
Solid Biosciences (SLDB)	United States	$0.426B	0.00
Entrada Therapeutics (TRDA)	United States	$0.420B	0.00
Forte Biosciences (FBRX)	United States	$0.418B	0.00
Eton Pharmaceuticals (ETON)	United States	$0.406B	0.00
Benitec Biopharma (BNTC)	United States	$0.396B	0.00
DiaMedica Therapeutics (DMAC)	United States	$0.394B	0.00
Rocket Pharmaceuticals (RCKT)	United States	$0.394B	0.00
Cybin (HELP)	Canada	$0.386B	0.00
Autolus Therapeutics (AUTL)	United Kingdom	$0.367B	0.00
Allogene Therapeutics (ALLO)	United States	$0.366B	0.00
Kyverna Therapeutics (KYTX)	United States	$0.366B	0.00
Enanta Pharmaceuticals (ENTA)	United States	$0.364B	0.00
BGM Group (BGM)	China	$0.362B	0.00
PepGen (PEPG)	United States	$0.357B	0.00
AC Immune (ACIU)	Switzerland	$0.352B	0.00
Tectonic Therapeutic (TECX)	United States	$0.352B	0.00
Candel Therapeutics (CADL)	United States	$0.351B	0.00
Greenwich LifeSciences (GLSI)	United States	$0.345B	0.00
Contineum Therapeutics (CTNM)	United States	$0.343B	0.00
Foghorn Therapeutics (FHTX)	United States	$0.340B	0.00
Neumora Therapeutics (NMRA)	United States	$0.338B	0.00
Aardvark Therapeutics (AARD)	United States	$0.335B	0.00
XOMA Royalty (XOMA)	United States	$0.327B	0.00
X4 Pharmaceuticals (XFOR)	United States	$0.324B	0.00
Puma Biotechnology (PBYI)	United States	$0.321B	8.61
Aura Biosciences (AURA)	United States	$0.319B	0.00
Eupraxia Pharmaceuticals (EPRX)	Canada	$0.315B	0.00
Zura Bio (ZURA)	United States	$0.313B	0.00
Lifecore Biomedical (LFCR)	United States	$0.308B	0.00
Amarin (AMRN)	Ireland	$0.307B	0.00
GENFIT S.A (GNFTY)	France	$0.299B	0.00
Immuneering (IMRX)	United States	$0.296B	0.00
Shattuck Labs (STTK)	United States	$0.294B	0.00
Climb Bio (CLYM)	United States	$0.288B	0.00
Abeona Therapeutics (ABEO)	United States	$0.285B	4.65
Neurogene (NGNE)	United States	$0.272B	0.00
Atea Pharmaceuticals (AVIR)	United States	$0.266B	0.00
Prenetics Global (PRE)	Hong Kong, SAR China	$0.264B	0.00
CAMP4 Therapeutics (CAMP)	United States	$0.263B	0.00
Adherex Technologies (FENC)	United States	$0.259B	0.00
Jyong Biotech (MENS)	Taiwan	$0.253B	0.00
Rezolute (RZLT)	United States	$0.253B	0.00
Nautilus Biotechnology (NAUT)	United States	$0.253B	0.00
Immix Biopharma (IMMX)	United States	$0.249B	0.00
Palisade Bio (PALI)	United States	$0.247B	0.00
Orchestra BioMed Holdings (OBIO)	United States	$0.238B	0.00
Adocia (ADOCY)	France	$0.231B	0.00
Nuvectis Pharma (NVCT)	United States	$0.217B	0.00
C4 Therapeutics (CCCC)	United States	$0.216B	0.00
Zentalis Pharmaceuticals (ZNTL)	United States	$0.214B	0.00
Cabaletta Bio (CABA)	United States	$0.212B	0.00
Voyager Therapeutics (VYGR)	United States	$0.209B	0.00
Humacyte (HUMA)	United States	$0.208B	0.00
Arcturus Therapeutics Holdings (ARCT)	United States	$0.207B	0.00
Alector (ALEC)	United States	$0.201B	0.00
Sagimet Biosciences (SGMT)	United States	$0.200B	0.00
Editas Medicine (EDIT)	United States	$0.198B	0.00
Quince Therapeutics (QNCX)	United States	$0.198B	0.00
Tiziana Life Sciences (TLSA)	United Kingdom	$0.196B	0.00
Cardiff Oncology (CRDF)	United States	$0.194B	0.00
Coherus Oncology (CHRS)	United States	$0.193B	0.00
Cartesian Therapeutics (RNAC)	United States	$0.193B	0.00
SAB Biotherapeutics (SABS)	United States	$0.189B	0.00
Crescent Biopharma (CBIO)	United States	$0.188B	0.00
Kalaris Therapeutics (KLRS)	United States	$0.182B	0.00
Alpha Teknova (TKNO)	United States	$0.178B	0.00
Milestone Pharmaceuticals (MIST)	Canada	$0.175B	0.00
ProQR Therapeutics (PRQR)	Netherlands	$0.174B	0.00
Molecular Partners AG (MOLN)	Switzerland	$0.170B	0.00
Rani Therapeutics Holdings (RANI)	United States	$0.169B	0.00
Vor Biopharma (VOR)		$0.164B	0.00
Innate Pharma S.A (IPHA)	France	$0.163B	0.00
Codexis (CDXS)	United States	$0.151B	0.00
Black Diamond Therapeutics (BDTX)	United States	$0.146B	7.11
Mersana Therapeutics (MRSN)	United States	$0.145B	0.00
Nkarta (NKTX)	United States	$0.145B	0.00
Opus Genetics (IRD)	United States	$0.145B	0.00
Seres Therapeutics (MCRB)	United States	$0.144B	0.00
Elicio Therapeutics (ELTX)	United States	$0.144B	0.00
VTv Therapeutics (VTVT)	United States	$0.140B	0.00
Fate Therapeutics (FATE)	United States	$0.137B	0.00
Whitehawk Therapeutics (WHWK)	United States	$0.137B	0.00
Caribou Biosciences (CRBU)	United States	$0.136B	0.00
Spero Therapeutics (SPRO)	United States	$0.136B	0.00
Sangamo Therapeutics (SGMO)	United States	$0.135B	0.00
MaxCyte (MXCT)	United States	$0.134B	0.00
Turn Therapeutics (TTRX)	United States	$0.134B	0.00
Anika Therapeutics (ANIK)	United States	$0.134B	0.00
Actuate Therapeutics (ACTU)	United States	$0.132B	0.00
Cognition Therapeutics (CGTX)	United States	$0.129B	0.00
Eledon Pharmaceuticals (ELDN)	United States	$0.127B	0.00
Alpha Cognition (ACOG)	Canada	$0.124B	0.00
Tenaya Therapeutics (TNYA)	United States	$0.121B	0.00
Connect Biopharma Holdings (CNTB)	United States	$0.121B	0.00
Sutro Biopharma (STRO)	United States	$0.118B	0.00
Fortress Biotech (FBIO)	United States	$0.115B	0.00
Acumen Pharmaceuticals (ABOS)	United States	$0.114B	0.00
Agenus (AGEN)	United States	$0.114B	0.00
Ovid Therapeutics (OVID)	United States	$0.112B	0.00
Repare Therapeutics (RPTX)	Canada	$0.111B	0.00
Tharimmune (THAR)	United States	$0.109B	0.00
Artiva Biotherapeutics (ARTV)	United States	$0.108B	0.00
Oncolytics Biotech (ONCY)	Canada	$0.107B	0.00
ANIXA BIOSCIENCES INC (ANIX)	United States	$0.106B	0.00
Seer (SEER)	United States	$0.105B	0.00
Genelux (GNLX)	United States	$0.104B	0.00
Mereo BioPharma Group - (MREO)	United Kingdom	$0.102B	0.00
Inovio Pharmaceuticals (INO)	United States	$0.101B	0.00
Tenax Therapeutics (TENX)	United States	$0.100B	0.00
Biomea Fusion (BMEA)	United States	$0.100B	0.00
Chrome Holding (MEHCQ)	United States	$0.096B	0.00
Scilex Holding (SCLX)	United States	$0.096B	0.00
Adverum Biotechnologies (ADVM)	United States	$0.096B	0.00
Starpharma Holdings (SPHRY)	Australia	$0.096B	0.00
Adagene (ADAG)	China	$0.092B	0.00
Coya Therapeutics (COYA)	United States	$0.090B	0.00
Citius Oncology (CTOR)	United States	$0.089B	0.00
EXoZymes (EXOZ)	United States	$0.088B	0.00
OKYO Pharma (OKYO)		$0.083B	0.00
BioHarvest Sciences (BHST)	Canada	$0.080B	0.00
Adicet Bio (ACET)	United States	$0.079B	0.00
Pliant Therapeutics (PLRX)	United States	$0.079B	0.00
Spruce Biosciences (SPRB)	United States	$0.079B	0.00
MediciNova (MNOV)	United States	$0.079B	0.00
XBiotech (XBIT)	United States	$0.078B	0.00
Annovis Bio (ANVS)	United States	$0.077B	0.00
Immunic (IMUX)	United States	$0.074B	0.00
Entera Bio (ENTX)	Israel	$0.074B	0.00
CalciMedica (CALC)	United States	$0.074B	0.00
ImageneBio (IMA)	United States	$0.073B	0.00
BioStem Technologies (BSEM)		$0.071B	4.94
Equillium (EQ)	United States	$0.070B	0.00
ATyr Pharma (ATYR)	United States	$0.069B	0.00
BeyondSpring (BYSI)	United States	$0.069B	0.00
Coeptis Therapeutics Holdings (COEP)	United States	$0.068B	0.00
CervoMed (CRVO)	United States	$0.067B	0.00
InflaRx (IFRX)	Germany	$0.067B	0.00
Tevogen Bio Holdings (TVGN)	United States	$0.067B	0.00
Adlai Nortye (ANL)	Cayman Islands	$0.066B	0.00
TScan Therapeutics (TCRX)	United States	$0.064B	0.00
ALX Oncology Holdings (ALXO)	United States	$0.063B	0.00
MIRA Pharmaceuticals (MIRA)	United States	$0.061B	0.00
Radiopharm Theranostics - (RADX)	Australia	$0.061B	0.00
Grace Therapeutics (GRCE)	United States	$0.056B	0.00
MiNK Therapeutics (INKT)	United States	$0.056B	0.00
Clene (CLNN)	United States	$0.055B	0.00
Precision BioSciences (DTIL)	United States	$0.054B	0.00
Zhengye Biotechnology Holding (ZYBT)	China	$0.052B	0.00
IBio (IBIO)	United States	$0.049B	0.00
ABVC BioPharma (ABVC)	United States	$0.049B	0.00
Aligos Therapeutics (ALGS)	United States	$0.049B	0.00
Instil Bio (TIL)	United States	$0.048B	0.00
PDS Biotechnology (PDSB)	United States	$0.047B	0.00
INmune Bio (INMB)	United States	$0.046B	0.00
Kezar Life Sciences (KZR)	United States	$0.045B	0.00
NextCure (NXTC)	United States	$0.045B	0.00
Anebulo Pharmaceuticals (ANEB)	United States	$0.045B	0.00
Q32 Bio (QTTB)	United States	$0.044B	0.00
Tvardi Therapeutics (TVRD)	United States	$0.043B	0.00
Jasper Therapeutics (JSPR)	United States	$0.043B	0.00
Cingulate (CING)	United States	$0.042B	0.00
TELA Bio (TELA)	United States	$0.041B	0.00
Passage Bio (PASG)	United States	$0.041B	0.00
OnKure Therapeutics (OKUR)	United States	$0.041B	0.00
BioXcel Therapeutics (BTAI)	United States	$0.040B	0.00
Galecto (GLTO)	Denmark	$0.040B	0.00
Exicure (XCUR)	United States	$0.040B	0.00
TuHURA Biosciences (HURA)	United States	$0.039B	0.00
Lantern Pharma (LTRN)	United States	$0.038B	0.00
Femasys (FEMY)	United States	$0.038B	0.00
Generation Bio (GBIO)	United States	$0.038B	0.00
Estrella Immunopharma (ESLA)	United States	$0.038B	0.00
RenovoRx (RNXT)	United States	$0.037B	0.00
Celularity (CELU)	United States	$0.037B	0.00
IO Biotech (IOBT)	Denmark	$0.036B	0.00
Oncobiologics (OTLK)	United States	$0.035B	0.00
Elutia (ELUT)	United States	$0.035B	0.00
Medicus Pharma (MDCX)	United States	$0.035B	0.00
Xilio Therapeutics (XLO)	United States	$0.034B	0.00
AN2 Therapeutics (ANTX)	United States	$0.033B	0.00
Atara Biotherapeutics (ATRA)	United States	$0.033B	2.08
Pluri (PLUR)	Israel	$0.032B	0.00
Skye Bioscience (SKYE)	United States	$0.032B	0.00
Rein Therapeutics (RNTX)	United States	$0.032B	0.00
Dyadic (DYAI)	United States	$0.031B	0.00
Alterity Therapeutics - (ATHE)	Australia	$0.031B	0.00
Barinthus Biotherapeutics (BRNS)	United States	$0.030B	0.00
Boundless Bio (BOLD)	United States	$0.028B	0.00
Rallybio (RLYB)	United States	$0.028B	0.00
Dare Bioscience (DARE)	United States	$0.028B	0.00
Aytu BioPharma (AYTU)	United States	$0.027B	0.00
Senti Biosciences (SNTI)	United States	$0.027B	0.00
Quantum Biopharma (QNTM)	Canada	$0.027B	0.00
Werewolf Therapeutics (HOWL)	United States	$0.027B	0.00
Hyperion DeFi (HYPD)	United States	$0.027B	0.00
Athira Pharma (ATHA)	United States	$0.027B	0.00
VistaGen Therapeutics (VTGN)	United States	$0.026B	0.00
Genenta Science S.p.A (GNTA)	Italy	$0.025B	0.00
Lixte Biotechnology Holdings (LIXT)	United States	$0.025B	0.00
Intensity Therapeutics (INTS)	United States	$0.025B	0.00
Cue Biopharma (CUE)	United States	$0.024B	0.00
Apollomics (APLM)	United States	$0.023B	0.00
FibroBiologics (FBLG)	United States	$0.022B	0.00
Neuphoria Therapeutics (NEUP)	United States	$0.022B	0.00
Pasithea Therapeutics (KTTA)	United States	$0.021B	0.00
CollPlant Biotechnologies (CLGN)	Israel	$0.019B	0.00
Lisata Therapeutics (LSTA)	United States	$0.019B	0.00
BioAtla (BCAB)	United States	$0.019B	0.00
Lexaria Bioscience (LEXX)	Canada	$0.019B	0.00
Allarity Therapeutics (ALLR)	United States	$0.019B	0.00
Cadrenal Therapeutics (CVKD)	United States	$0.018B	0.00
Promis Neurosciences (PMN)	Canada	$0.018B	0.00
Polyrizon (PLRZ)	Israel	$0.016B	0.00
Hoth Therapeutics (HOTH)	United States	$0.016B	0.00
Black Titan (BTTC)	United States	$0.015B	0.00
Applied Therapeutics (APLT)	United States	$0.015B	0.00
Cocrystal Pharma (COCP)	United States	$0.015B	0.00
Bionano Genomics (BNGO)	United States	$0.015B	0.00
BioCardia (BCDA)	United States	$0.015B	0.00
Soligenix (SNGX)	United States	$0.014B	0.00
Beyond Air (XAIR)	United States	$0.014B	0.00
Sensei Biotherapeutics (SNSE)	United States	$0.013B	0.00
Synlogic (SYBX)	United States	$0.013B	0.00
Curis (CRIS)	United States	$0.013B	0.00
Bolt Biotherapeutics (BOLT)	United States	$0.012B	0.00
Edesa Biotech (EDSA)	Canada	$0.012B	0.00
Novogen (KZIA)	Australia	$0.012B	0.00
Longeveron (LGVN)	United States	$0.012B	0.00
Imunon (IMNN)	United States	$0.011B	0.00
IN8bio (INAB)	United States	$0.011B	0.00
NewcelX (NCEL)	Switzerland	$0.011B	0.00
Mainz Biomed (MYNZ)	Germany	$0.011B	0.00
Chemomab Therapeutics (CMMB)	Israel	$0.010B	0.00
Biorestorative Therapies (BRTX)	United States	$0.010B	0.00
Akari Therapeutics (AKTX)	United Kingdom	$0.010B	0.00
Gelteq (GELS)	Australia	$0.010B	0.00
Biofrontera (BFRI)	United States	$0.010B	0.00
Abpro Holdings (ABP)	United States	$0.010B	0.00
GENPREX (GNPX)	United States	$0.009B	0.00
Cuprina Holdings (Cayman) (CUPR)	Singapore	$0.009B	0.00
Alzamend Neuro (ALZN)	United States	$0.009B	0.00
Aptevo Therapeutics (APVO)	United States	$0.009B	0.00
IMMURON (IMRN)	Australia	$0.009B	0.00
Moleculin Biotech (MBRX)	United States	$0.008B	0.00
Purple Biotech (PPBT)	Israel	$0.008B	0.00
BRIACELL THERAP (BCTX)	Canada	$0.008B	0.00
GT Biopharma (GTBP)	United States	$0.008B	0.00
Mustang Bio (MBIO)	United States	$0.008B	0.00
Silexion Therapeutics Corp (SLXN)	Israel	$0.007B	0.00
MetaVia (MTVA)	United States	$0.007B	0.00
KALA BIO (KALA)	United States	$0.007B	0.00
Advanced Biomed (ADVB)	United States	$0.006B	0.00
Dogwood Therapeutics (DWTX)	United States	$0.006B	0.00
Adial Pharmaceuticals (ADIL)	United States	$0.006B	0.00
Acurx Pharmaceuticals (ACXP)	United States	$0.006B	0.00
Aprea Therapeutics (APRE)	United States	$0.006B	0.00
BioAffinity Technologies (BIAF)	United States	$0.006B	0.00
Sunshine Biopharma (SBFM)	United States	$0.006B	0.00
Aspire Biopharma Holdings (ASBP)	United States	$0.006B	0.00
Evogene (EVGN)	Israel	$0.006B	0.00
Revelation Biosciences (REVB)	United States	$0.006B	0.00
VivoSim Labs (VIVS)	United States	$0.005B	0.00
Cyclerion Therapeutics (CYCN)	United States	$0.005B	0.00
Creative Medical Technology Holdings (CELZ)	United States	$0.005B	0.00
Silo Pharma (SILO)	United States	$0.005B	0.00
Avalon GloboCare (ALBT)	United States	$0.005B	0.00
HCW Biologics (HCWB)	United States	$0.005B	0.00
CNS Pharmaceuticals (CNSP)	United States	$0.004B	0.00
Propanc Biopharma Inc (PPCB)	Australia	$0.004B	0.00
AquaBounty Technologies (AQB)	United States	$0.004B	0.00
GeoVax Labs (GOVX)	United States	$0.004B	0.00
Alps Group (ALPS)	United States	$0.003B	3.00
Artelo Biosciences (ARTL)	United States	$0.003B	0.00
Cardio Diagnostics Holdings (CDIO)	United States	$0.003B	0.00
Arcadia Biosciences (RKDA)	United States	$0.003B	0.00
Bone Biologics (BBLG)	United States	$0.003B	0.00
Ensysce Biosciences (ENSC)	United States	$0.003B	0.00
Scinai Immunotherapeutics (SCNI)	Israel	$0.003B	0.00
Onconetix (ONCO)	United States	$0.003B	0.00
Dermata Therapeutics (DRMA)	United States	$0.002B	0.00
Enveric Biosciences (ENVB)	United States	$0.002B	0.00
Biodexa Pharmaceuticals (BDRX)	United Kingdom	$0.001B	0.00
Virax Biolabs Group (VRAX)	United Kingdom	$0.001B	0.00
Psyence Biomedical (PBM)	Canada	$0.001B	0.00
GRI Bio (GRI)	United States	$0.001B	0.00
NuCana (NCNA)	United Kingdom	$0.000B	0.00
Aceragen (ACGN)	United States	$0.000B	0.00
ARAVIVE, INC (ARAV)	United States	$0.000B	0.00
Compugen (CGEN)	Israel	$0.000B	0.00
Cellectis S.A (CLLS)	France	$0.000B	0.00
Clovis Oncology (CLVSQ)	United States	$0.000B	0.00
Celyad SA (CYAD)	Belgium	$0.000B	0.00
CytoMed Therapeutics (GDTC)	Singapore	$0.000B	0.00
Galapagos (GLPG)	Belgium	$0.000B	0.00
Motif Bio Plc (MTFB)	United Kingdom	$0.000B	0.00
NeuroSense Therapeutics (NRSN)	Israel	$0.000B	0.00
PDL BioPharma (PDLI)	United States	$0.000B	0.00
Pharvaris (PHVS)	Netherlands	$0.000B	0.00
Pulmatrix (PULM)	United States	$0.000B	0.00
TFF Pharmaceuticals (TFFP)	United States	$0.000B	0.00
VectivBio Holding AG (VECT)	Switzerland	$0.000B	0.00